Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Sep 3, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Goodwill (2024 - 2026)

Revium Rx's (RVRC) quarterly Goodwill came in at $2.6 million in Q2 2026, little changed quarter-over-quarter from $2.6 million in Q4 2025.

Analysis

Revium Rx (RVRC) Goodwill (2024 - 2026) Analysis & Trends

Revium Rx has disclosed Goodwill across 3 years of filings, most recently posting $2.6 million for Q2 2026.

  • In Q2 2026, Goodwill changed N/A year-over-year to $2.6 million; the TTM figure through Jun 2026 stood at $2.6 million (changed N/A YoY), while the FY2025 annual figure was $2.6 million, down 77.44% from the prior year.
  • Goodwill came in at $2.6 million for Q2 2026 at Revium Rx, roughly flat from $2.6 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $11.4 million in Q4 2024 to a low of $2.6 million in Q4 2025.
  • Average Goodwill over 3 years is $5.5 million, with a median of $2.6 million recorded in 2025.
  • The largest YoY upside for Goodwill was 77.44% in 2025 against a maximum downside of 77.44% in 2025.
  • Over 3 years, Goodwill stood at $11.4 million in 2024, then sank by 77.44% to $2.6 million in 2025, then changed by 0.0% to $2.6 million in 2026.
  • Per Business Quant data, the three most recent Goodwill figures were $2.6 million in Q2 2026, $2.6 million in Q4 2025, and $11.4 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Revium Rx 86.84 Mn 85.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.58 Mn
Dec 31, 2025 2.58 Mn
Dec 31, 2024 11.41 Mn